Home › Biotech Rival to Teva's Blockbuster Said to Seek $40 Million IPO
 

Keywords :   


Biotech Rival to Teva's Blockbuster Said to Seek $40 Million IPO

2014-03-24 02:04:10| Biotech - Topix.net

Mapi Pharma Group, which is developing a longer acting version of Teva's blockbuster Copaxone drug, is considering selling shares in the U.S., a person with knowledge of the matter said.

Tags: million seek ipo biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.10Atlantic Tropical Weather Outlook
05.10Eastern North Pacific Tropical Weather Outlook
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
More »